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EXECUTIVE SUMMARY 
This report describes the 12-month diagnosed prevalence of behavioral health disorders (BHDs) 
among Massachusetts Medicare and Medicaid (MassHealth) members 55 years of age and older 
during calendar year 2005.  Although population-based estimates of prevalence of BHDs among 
the elderly are available in only a few selected studies, none of them describe Massachusetts.  
With an expected rise in the number of elderly people with psychiatric disorders, a better 
understanding of the prevalence of mental illness and addictions in this population is needed to 
plan for services and supports.     
 
This study used merged Medicare and MassHealth claims data to examine 12-month diagnosed 
prevalence of BHDs.  BHDs were organized into three groups: severe mental illness 
(schizophrenia/other paranoid disorders, bipolar disorder, and major depression), other mental 
illness (other depression, anxiety, and others), and substance use disorders (alcohol/drug abuse or 
dependence).  Furthermore, fifteen chronic medical conditions with high prevalence among 
elders were selected as measures of medical comorbidity. BHDs and chronic conditions were 
identified primarily by diagnoses recorded on health insurance claims. 
 
This study also examined the relationships between BHD prevalence, primary health care 
payment source, and age.  Primary payment sources included Medicare Only, MassHealth Only, 
and Dual Eligibles (dually eligible for both Medicare and MassHealth).  Age was broken into 
four groups: 55 to 64, 65 to 74, 75 to 84, and 85 and over.  The under 65 study group (55 to 64) 
represented 25% of all Massachusetts residents between the ages of 55 and 64; the 65 and over 
groups (when combined) captured 80% of residents in those age groups.  A distinguishing 
feature of the study population was that most of those in the under 65 group qualified for 
Medicare or Medicaid due to a disability, while most of those 65 and older qualified for 
Medicare due to old age.  In addition, those who were Dual Eligibles were more likely to have 
lower income, to be older, and to have disabilities than those in the Medicare Only or 
MassHealth Only groups. 
 
Significant findings included the following: 
 
• The 12-month diagnosed prevalence of BHDs was 20.8% (N=168,960) for 
Massachusetts Medicare and Medicaid (MassHealth) beneficiaries aged 55 and over 
during calendar year 2005 (N=813,098).   
 
• Dual Eligibles had a higher diagnosed prevalence of BHDs than the Medicare Only 
and MassHealth Only groups. In the 55 to 64 age group, the diagnosed prevalence of 
any BHD among Dual Eligibles (51.7%) was 4 times higher than in the Medicare Only 
group (12.9%) and more than 1.5 times higher than in the MassHealth Only group 
(31.2%).  Although the differences between Dual Eligibles and the other groups are 
smaller among those aged 65 and over, the diagnosed prevalence among Dual Eligibles 
(38.8%) was almost 2.5 times higher than the Medicare Only group (16.1%). 
 
• Dual Eligibles had a higher proportion of people with multiple BHDs than the 
Medicare Only and MassHealth Only groups.  Among Dual Eligibles aged 55 to 64, 
64.0% of people with severe mental illness also had at least one other psychiatric 
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diagnosis and 16.3% of people with severe mental illness had a co-occurring alcohol or 
drug use disorder. In addition, 50% of those with a substance use disorder had co-
occurring severe mental illness.  For people 65 and over, 70.3% of people with severe 
mental illness had a co-occurring psychiatric disorder and 7.7% had a co-occurring 
substance use disorder.  In addition, 35.5% of those with a substance use disorder had co-
occurring severe mental illness. 
 
• Regardless of age group or primary payment source, a much higher proportion of 
people with BHDs had 5 or more selected chronic medical conditions than those who 
had no BHD.  In addition, the proportion of people with 5 or more chronic medical 
conditions was highest among Dual Eligibles with BHDs.  Among Dual Eligibles aged 55 
to 64, 20.8% of people with BHDs had 5 or more chronic medical conditions compared 
to 13.0% of those who had no BHD; 49.2% of members aged 65 and over with BHDs 
and 23.3% without BHDs had 5 or more chronic conditions.  
 
In conclusion, almost 170,000 Massachusetts Medicare and Medicaid enrollees aged 55 and over 
had BHD diagnoses recorded on health insurance claims and their overall disease burden was 
higher than those without a BHD.  Innovative programs and better coordination with other 
medical care services need to be developed to address challenges posed by the increasing number 
of elderly people with BHDs and their high disease burden.  Further analyses underway at 
UMMS will provide information on mental health services currently being used by this 
population in order to identify opportunities for systematic changes to better serve elders with 
BHDs. 
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1. INTRODUCTION 
 
As the baby boom generation ages, it is estimated that the elderly population will increase from 
34 million individuals in 2000 to 69 million in the year 2030 (Day, 1996).  In addition, it is 
estimated that the number of elderly people with psychiatric disorders will disproportionally 
increase from 7 million in 2000 to 15 million in 2030 (Jeste et al., 1999).  Reasons for the 
substantial increase in elderly people with psychiatric disorders include the anticipated increase 
in the number of elderly people; a higher likelihood of depressive, anxiety, and substance use 
disorders in this population (Klerman & Weissman, 1989; White, Aidals, & Zablocki, 1988); and 
longer life expectancy of those who had psychiatric disorders earlier in life (Jeste et al., 1999). 
 
This increase in the number of older adults with psychiatric disorders poses serious challenges to 
the current mental health care delivery system in terms of health care financing, workforce 
training in geriatric mental health, and coordination with other medical care services.  
Nevertheless, existing population-based prevalence estimates for the elderly population are 
available in only a few selected studies.  Therefore, a better understanding of the prevalence of 
psychiatric disorders in the elderly population is needed to plan for services and supports.     
 
This report presents findings on the 12-month diagnosed prevalence of behavioral health 
disorders (BHDs) in Massachusetts Medicare beneficiaries and Medicaid (MassHealth) members 
aged 55 and over during the calendar year 2005.  This is a population-based study and the BHDs 
were grouped into three categories: severe mental illness (schizophrenia/other paranoid 
disorders, bipolar disorder, and major depression), other mental illness (other depression, 
anxiety, and others), and substance use disorders (alcohol/drug abuse or dependence).  
Furthermore, fifteen chronic medical conditions with high prevalence among elders were 
selected as measures of medical comorbidity.  BHDs and chronic conditions were identified 
primarily by diagnoses recorded on health insurance claims.  In this study, Alzheimer’s disease 
and other dementias were not treated as BHDs, but instead were addressed in the discussion of 
medical comorbidities. 
 
This report is one deliverable from a comprehensive study of elder mental health that is currently 
underway as part of a collaboration between the Executive Office of Elder Affairs and the 
University of Massachusetts Medical School/Commonwealth Medicine.  The diagnosed 
prevalence of BHDs reported here is the first part of a larger Medicare and Medicaid claims data 
analysis.  Further analyses will provide information on use of mental health services in order to 
identify opportunities for systematic changes to better serve elders with BHDs. 
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2. BACKGROUND 
 
2.1 Prevalence of Mental Disorders Based on Epidemiologic Studies 
 
Efforts to study the prevalence of mental disorders in the U.S. population in a comprehensive 
manner began in the 1980s using data from large epidemiologic studies.  The most often cited 
prevalence of mental disorders either in the adult population as a whole, or in older adults, relies 
on estimates from three large surveys supported by the National Institute of Mental Health 
(NIMH): the Epidemiologic Catchment Area (ECA) survey, the National Comorbidity Survey 
(NCS), and the National Comorbidity Survey-Replication (NCS-R) studies.  The ECA Survey 
(1980-85) has been a major source of prevalence data on the adult U.S. population for over two 
decades.  This study used the NIMH Diagnostic Interview Schedule (DIS) to estimate prevalence 
of mental and addictive disorders, including severe cognitive impairment, that were listed in the 
Diagnostic and Statistical Manual of Mental Disorders, Third Edition (DSM-III) (D. A. Regier et 
al., 1984).  The ECA study also examined treatments received for these disorders.  The ECA 
study population included adults aged 18 and over in 5 sites.  Based on study findings, one-year 
prevalence of any mental disorder was reported to be 28.1% (Darrel A Regier et al., 1993).  
Regarding specific mental illness diagnoses, one-year prevalence was reported for major 
depression at 5.0%, schizophrenia at 1.1%, and bipolar disorder at 1.2% (Darrel A Regier et al., 
1993).     
 
Although the ECA study was the first survey to use fully structured research diagnostic 
interviews to examine the prevalence of mental disorders, it was implemented in only 5 sites and 
questions remained as to whether results held at the national level. In order to address the issue 
of representativeness, NIMH sponsored the NCS (in 1990 and 1992) to examine prevalence and 
correlates of mental disorders in a nationally representative sample of adults aged 18 to 54.  The 
NCS used the World Health Organization’s Composite International Diagnostic Interview (CIDI) 
to identify the presence of mental health diagnoses based on the DSM-III-R.  In contrast to the 
ECA study, severe cognitive impairment was not included in the mental disorders examined by 
the NCS study.  One-year overall prevalence of DSM-III-R mental disorders in the NCS study 
was reported to be 30.2% for persons aged 18 to 54 (Ronald C. Kessler et al., 1994).   
 
The NCS study was replicated in 2001-2003 (NCS-R).  The NCS-R study employed a different 
sampling scheme that included individuals 55 and older and used a substantially expanded 
interview form that assessed disorder severity in addition to prevalence (Ronald C Kessler, Chiu, 
Demler, & Walters, 2005).  In the NCS-R, 12-month prevalence of any DSM-IV disorder for all 
ages (including 55 and over) was reported to be 26.2%.  Twelve-month prevalence of major 
depression in this sample, which included older adults, was 6.7% and bipolar disorder was 2.6% 
(Ronald C Kessler et al., 2005).  The NCS-R also categorized mental disorders by severity, but 
used much more comprehensive criteria, including functional status, risk of suicide and duration 
of symptoms, than the original NCS survey.  Among those with any mental disorder, 22.3% of 
respondents were classified as having a “serious” mental disorder (Ronald C Kessler et al., 
2005).   
 
Any study of the prevalence of mental disorders depends greatly on the measurement tools and 
criteria used.  Attempts have been made to reconcile the discrepant prevalence estimates of the 
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ECA and NCS studies, chiefly by accounting for changes in diagnostic criteria between the 
DMS-III and DSM-III-R and by looking more closely at clinical significance of symptoms 
(Narrow, Rae, Robins, & Regier, 2002; D. A. Regier et al., 1998).  Applying more stringent and 
consistent criteria to both sets of data, the disparities between the two surveys decreased, and the 
one-year prevalence rates dropped significantly in both surveys.  In the NCS, for example, the 
prevalence of major depression was 10.1% before the criteria were applied and 6.4% after the 
new criteria were applied (Narrow et al., 2002).  For any mental disorder (not including severe 
cognitive impairment), the one-year prevalence dropped from 30.2% to 20.6% (Narrow et al., 
2002).  However, it is important to remember that data for the original NCS were collected only 
for adults aged 18 – 54 and findings may not be applicable to older adults. 
 
For the ECA study (where the sample did include people 55 and older, as well as people with 
severe cognitive impairment) the prevalence estimates changed less dramatically for mental 
disorders, but still decreased when the clinical significance criterion was applied.  For all ages 
(18 and older) the one-year prevalence of any disorder went from 28.0% to 22.5% (Narrow et al., 
2002).  Narrow and colleagues (2002) also reported 12-month prevalence of mental disorders in 
the ECA study by two age groups: 18 to 54 and 55 and over.  After applying the clinical 
significance criterion, the estimates dropped from 29.6% to 24.7% for people aged 18 to 54 and 
from 24.0% to 17.3% for people aged 55 and over.  Regarding specific mental disorders, one-
year revised prevalence with the clinical significance criterion was 5.2% for major depression, 
1.3% for schizophrenia, and 0.9% for bipolar disorder in people aged 18 to 54, while the 
prevalence was 2.7%, 0.4%, and 0.2%, respectively, in people aged 55 and over (Narrow et al., 
2002). 
 
In addition to the ECA, NCS, and NCS-R surveys noted above, there are several studies of 
prevalence that are more narrowly focused on specific populations or disorders.  The 2002 
National Survey on Drug Use and Health (a survey of the non-institutionalized population of the 
U.S. aged 12 and older) reported that approximately 8.3% of the adult population aged 18 and 
older was estimated to have serious mental illness (Epstein, Barker, Vorburger, & Murtha, 2004).  
However, neither prevalence rates for the older population nor specific diagnoses were studied. 
 
The National Survey of American Life (NSAL) is one of the few national studies that 
specifically examined prevalence of DSM-IV mental disorders in a sample of non-white people.  
The NSAL is a national household probability sample of non-institutionalized African 
Americans, Caribbean blacks, and non-Hispanic whites aged 18 and older in the U.S. (Jackson et 
al., 2004).  A recent study used the NSAL to study prevalence of major depressive disorders and 
found that the 12-month prevalence was highest for Caribbean blacks (7.2%) followed by whites 
at 6.9% and African Americans at 5.9% (Williams et al., 2007).   The study did not focus 
specifically on older adults, however. 
 
Another study recently used a large national data set to examine prevalence of mental illness in 
older Hispanics.  Data from the third wave of the Health and Retirement Study (HRS) and the 
second wave of the Health Dynamics of the Oldest Old (AHEAD) study were used to examine 
prevalence of depression in Hispanic adults aged 59 and older, and results were reported for 
Puerto Rican, Mexican American, Cuban and “Other” Hispanics on both severity and prevalence 
of depression based on criteria set forth in the DSM-III (Yang, Cazorla-Lancaster, & Jones, 
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2008).  The study found that the unadjusted one-year prevalence of major depression was 16.9% 
for Puerto Rican, 9.7% for Cuban, 4.8% for Other Hispanic groups, and 4.1% for Mexican 
American (Yang et al., 2008). 
 
Studies have also shown that the “Mental Component Score” derived from the SF-36, a general 
health status assessment instrument (Ware, Snow, Kosinski, & Gandek, 1993), is a valid 
screening tool for depression (Berwick et al., 1991; Beusterien, Steinwald, & Ware, 1996; Wells 
et al., 1989).  When comparing to results obtained using the NIMH Diagnostic Interview 
Schedule, a “Mental Component Score” of 42 or below yielded the highest sensitivity (74%) and 
specificity (81%) in identifying people with DSM III diagnoses of major depression or 
dysthymia (Wells et al., 1989).  Using the “Mental Component Score” from the Health Outcome 
Survey for Medicare fee-for-service beneficiaries, a study found one-month prevalence of major 
depression or dysthymia to be 29.9% across all Medicare beneficiaries and 25.0% for elderly 
Medicare beneficiaries (McCall, Parks, Smith, Pope, & Griggs, 2002).   
 
The large national studies discussed above, including the ECA, the NCS and NCS-R, the NSAL, 
the HRS and the AHEAD, have all estimated the prevalence of mental disorders in the U.S. 
population.  However, not all of these have specifically focused on older adults.  In addition, 
diagnostic criteria for mental illnesses have differed across surveys.   
 
 
2.2 Prevalence of Mental Disorders Based on Claims Data 
 
In contrast to the epidemiologic studies described above, studies that use claims data to estimate 
prevalence of mental disorders draw diagnostic information from insurance claims for services 
delivered.  Prevalence estimates derived from claims data account only for individuals with 
mental health diagnoses that were recorded in insurance claims.   
 
Crystal and colleagues (2003) studied the prevalence of depression in the elderly Medicare 
population using merged claims and interview data from the 1992 – 1998 Medicare Current 
Beneficiary Survey, a nationally representative sample of Medicare recipients (Crystal, 
Sambamoorthi, Walkup, & Akincigil, 2003).  The authors examined diagnosed depression data 
based on the ICD-9-CM codes in the claims data.  The study examined major depressive disorder 
and other depression and found that the prevalence of any diagnosed depression in the elderly 
population increased from 2.8% in 1992 to 5.8% in 1998 (Crystal et al., 2003).   
 
Another study based on insurance claims estimated the 12-month diagnosed prevalence of 
schizophrenia, weighted by insurance coverage type in a merged data set (private insurance, 
Medicare, California-Medicaid, and uninsured) (Wu, Shi, Birnbaum, Hudson, & Kessler, 2006).  
This study found that the12-month prevalence of schizophrenia was 1.66% among Medicaid 
only members (under 65 years old) and 0.83% among Medicare beneficiaries; 0.55% for males 
and 0.84% for females aged 65 and older in the entire study population. 
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2.3 Prevalence of Mental Disorders in Nursing Home Residents 
 
The reported prevalence of mental disorders in nursing home residents has changed over time.   
In the 1997 National Nursing Home Survey, the category “mental disorders, including 
dementia”, was the second most frequent diagnostic category (15.6%) at the time of nursing 
home admission (Gabrel, 2000).  Mechanic and McAlpine (2000) compared data in the 1985 and 
1995 National Nursing Home Survey and found that the prevalence of depression increased from 
4.1% to 12.1% and the prevalence of dementia-related conditions increased from 27.8% to 
41.0%, while the prevalence of schizophrenia decreased from 9.8% to 7.1% (Mechanic & 
McAlpine, 2000).  A further examination of the 1987 and 1996 nursing home component of the 
Medical Expenditure Panel Survey found a consistent pattern of changes (Mechanic & 
McAlpine, 2000).  However, the increase in the prevalence of depression mostly appeared as a 
secondary diagnosis.  The authors concluded that, except for elderly people with dementia, 
nursing homes play a minor role in providing mental health services (Mechanic & McAlpine, 
2000). 
 
 
2.4 Summary 
 
In summary, estimates of the overall prevalence of mental disorders have ranged from 22.5% to 
28.1% for the population aged 18 and over.  For the population aged 18 to 54, the estimates were 
higher, at 20.6% to 30.26%.  For those aged 55 and over, estimates ranged from 17.3% to 24.0%.  
 
Regarding the prevalence of specific mental disorders, estimates have ranged from 5% to 10.1% 
for major depression in adults aged 18 and over and from 2.7% to 3.7% for those who aged 55 
and over.  The prevalence of schizophrenia was around 1% and the prevalence of bipolar 
disorder ranged from 1.2% to 2.6%. 
 
The following sections in this report describe methods and present findings on 12-month 
diagnosed prevalence of behavioral health disorders (BHDs) in Medicare beneficiaries and 
Medicaid (MassHealth) members aged 55 and over in Massachusetts during calendar year 2005.   
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3. METHODS 
3.1 Data Sources 
 
The main data sources used in this analysis included Medicare data, MassHealth data, and a 
Medicare and MassHealth linkage file; all data were from the Calendar year 2005.  Unique 
identifiers within the first two data sets allowed linkage between denominator/eligibility data and 
various claims data.  Individuals dually eligible for Medicare and Massachusetts Medicaid 
(MassHealth) were identified from the linkage file.  The contents of these main data sources are 
described below. 
 
• Medicare Data (Centers for Medicare and Medicaid Services), Calendar Year 2005 included: 
- The Denominator file 
- Institutional and non-institutional claims data 
 
• MassHealth Data (Massachusetts Executive Office of Health and Human Service Data 
Warehouse), Calendar Year 2005 included: 
- Eligibility data 
- Medicaid Management Information System (MMIS) claims data 
- Managed Care Organizations (MCO) encounter data 
- Massachusetts Behavioral Health Partnership (MBHP) encounter data 
 
• Medicare and MassHealth linkage file (Centers for Medicare and Medicaid Services) 
included: 
- A linkage variable that allowed the data to be linked with unique identifiers in Medicare 
and MassHealth data for individuals who were dually eligible for Medicare and 
MassHealth in calendar year 2005 
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3.2 Study Population 
 
The study population included Medicare beneficiaries and MassHealth members aged 55 years 
or older as of January 1, 2005, excluding people who were enrolled in Medicare managed care 
for the entire Medicare coverage period in CY 2005, for whom claims data were incomplete.  In 
other words, an individual was included in the study population if he/she stayed in the fee-for-
service sector for a month or more, in CY 2005, regardless of managed care enrollment.  This 
approach was consistent with our intention to include the full population to the extent possible in 
reporting the prevalence.   
 
The study population (N=813,908) was further classified into three groups based on primary 
payment sources for health services claims.  The three groups were: 
• Dual Eligibles (N=138,379): enrolled in Medicare Part A or Part B for at least one day and 
enrolled in MassHealth for at least one day during CY05.  
• Medicare Only (N=613,193): enrolled in Medicare Part A or Part B for at least one day and 
did not enroll in MassHealth at all during CY05 
• MassHealth Only (N=62,336): enrolled in MassHealth for at least one day during CY05 and 
did not enroll in Medicare at all during CY05 
 
Figure 3.1 shows how the study population (N=813,908) was derived. 
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Figure 3.1 Derivation of the Study Population  
 
 
Note:  1. Dual eligibility was not consistent between data sources for these individuals.  
 2. Individuals enrolled in Medicare managed care for their entire Medicare coverage 
period in CY 2005.  Those who were enrolled in Medicare fee-for-service sector for 
any portion of time were included in the study population regardless their managed 
care enrollment during the remainder of CY 2005.  
 
Enrolled in Medicare (CY05), 
all ages 
N=1,016,690 
Enrolled in MassHealth (CY05), 
age>=55 as of 1/1/05 
N=217,116 
Dual Eligible (from 
Medicare linking file) 
N=236,020 
Medicare Only,  
age >=55 as of 1/1/05 
N=753,070 
Not in MassHealth
1
 
N=3,754 
MassHealth Only 
age >=55 as of 1/1/05 
N=62,336 
Dual Eligible 
age >=55 as of 1/1/05 
N=154,780 
Medicare Only,  
age < 55 as of 1/1/05 
N=27,600 
Age<55 as of 1/1/05 
N=77,486 
Medicare Only 
N=613,193 
Dual Eligible 
N=138,379 
MassHealth Only 
N=62,336 
Enrolled in 
Medicare 
managed care
2
 
N=139,877 
Enrolled in 
Medicare 
managed care
2
 
N=16,401
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3.3. Disease Identification 
 
Twelve-month diagnosed prevalence was reported in the study.  Behavioral health disorders and 
medical comorbidity were primarily classified based on the ICD-9-CM codes used in Medicare 
and MassHealth claims.  Individuals were identified for inclusion in the study by having at least 
one claim with the specified diagnosis or procedure codes, either principal or others.  These 
disease categories were not mutually exclusive.  A list of these diagnosis and procedure codes is 
included in Appendix A1 and A2. 
 
 
3.3a Behavioral health disorders 
 
We grouped behavioral health disorders (BHDs) into three groups: severe mental illness, other 
mental illness, and substance use disorders.  Below is a list of diseases included in each of the 
three groups of BHDs.   
• Severe mental illness (SMI): schizophrenia/paranoid, bipolar disorder, and major depression. 
• Other mental illness (OMI): other depression, anxiety, and others. 
• Substance use disorders (SUD): alcohol abuse or dependence and drug abuse or dependence. 
 
 
3.3b Comorbidity of chronic conditions 
 
Fifteen conditions were selected as measures of medical comorbidity. These included major 
chronic conditions and diseases that studies have shown to be prevalent among in elderly people. 
Conditions (arranged by major diagnostic classifications) included diabetes, chronic kidney 
disease, atrial fibrillation, ischemic heart disease, congestive heart disease, hypertension, stroke, 
asthma/chronic obstructive pulmonary diseases, rheumatoid arthritis/osteoarthritis, osteoporosis, 
hip/pelvic fracture, Parkinson’s disease, dementia/Alzheimer’s disease, eye diseases (cataract, 
glaucoma, and macular degeneration), and cancer. 
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4. RESULTS 
 
Demographic characteristics, Medicare enrollment status, and MassHealth (Massachusetts 
Medicaid) enrollment status of the study population are described in Sections 4.1 to 4.3.  Results 
are shown by primary payment source, which includes Medicare Only, MassHealth Only, and 
Dual Eligibles (dually eligible for both Medicare and MassHealth).   
 
Sections 4.4 to 4.6 present 12-month diagnosed prevalence of behavioral health disorders 
(BHDs), multiple BHDs, and selected chronic physical comorbidities by primary payment source 
and by age group.  Section 4.7 presents geographic variation in diagnosed prevalence of BHDs 
among counties. 
 
In these sections, age data is reported for four age groups: 55 to 64, 65 to 74, 75 to 84, and 85 
and over.  The under 65 study group (55 to 64, N=134,276) represented 25% of all 
Massachusetts residents between the ages of 55 and 64, while the over 65 groups (when 
combined N=679,182) captured 80% of residents in those age groups. In Figures 4.4b to 4.6c, an 
asterisk (*) and a double asterisk (**) are used to indicate that these age groups represent 
different percentages of the population. (The * is used for the under 65 group and the ** is used 
for the over 65 age groups.)  
 
In discussing results, we often combine the 65 and over age groups when they show similar 
patterns. In addition, we often do not include the MassHealth Only group in the discussion 
because it has a small sample size and results may not be reliable.  However, results for all three 
primary payment sources and all four age groups are shown in the following figures.  In addition, 
exact numbers and percentages are shown in the Appendices. 
 
Significant findings include the following: 
• The 12-month diagnosed prevalence of BHDs was 20.8% (N=168,960) for Massachusetts 
Medicare and Medicaid (MassHealth) beneficiaries aged 55 and over during calendar 
year 2005 (N=813,098).   
• Dual Eligibles had a higher diagnosed prevalence of BHDs than the Medicare Only and 
MassHealth Only groups.  
• Dual Eligibles had a higher proportion of people with multiple BHDs than the Medicare 
Only and MassHealth Only groups.  
• Regardless of age group or primary payment source, a much higher proportion of people 
with BHDs had 5 or more selected chronic medical conditions than those who had no 
BHD.   
 
 
 Twelve-Month Diagnosed Prevalence of Behavioral Health Disorders 
January 2009│Final Version 
13
4.1 Demographic Characteristics by Primary Payment Source 
(Refer to Table 4.1) 
 
• In our study population of Massachusetts residents aged 55 or older enrolled in Medicare 
and/or MassHealth during calendar year 2005 (N=813,908), 75% were Medicare Only 
(N=613,193), 17% were dually eligible for Medicare and MassHealth (N=138,379), and 8% 
were MassHealth Only (N=62,336). 
• Although the average age was similar for the Dual Eligibles and Medicare Only group, the 
former had a higher proportion of people aged 55 to 64 (22%) and 85 and over (18%) 
compared to the latter group, which had 10% and 13%, respectively. 
• MassHealth Only members were much younger than the Dual Eligibles and Medicare Only 
group and 70% of MassHealth Only group were between 55 and 64 years of age. 
• Dual Eligibles had the highest proportion of female members (68%), followed by 
MassHealth Only (61%) and Medicare Only (56%) 
• The majority of Medicare Only members were white (95%), followed by Dual Eligibles 
(78%); around 30% of MassHealth Only members did not report race in their eligibility 
records. 
 
Table 4.1 Demographic Characteristics by Primary Payment Source, CY 2005 
CY 2005 
(Total N=813,908) 
Dual Eligibles 
(N=138,379) 
Medicare Only 
(N=613,193) 
MassHealth Only 
(N=62,336) 
Demographic Characteristics, N (%)   
Age (Mean) 74 (SD=10.8) 74 (SD=8.7) 64 (SD=9.0) 
55 to 64 30,677 (22%) 60,967 (10%) 43,082 (70%) 
65 to 74 44,602 (33%) 267,251 (44%) 10,795 (17%) 
75 to 84 37,791 (27%) 207,670 (34%) 5,689   (9%) 
>=85 25,309 (18%) 77,305 (13%) 2,770   (4%) 
Male 44,351 (32%) 325,901 (44%) 24,304 (39%) 
Race (based on Medicare data) (based on Medicare data) (based on MassHealth data) 
White 107,367 (78%) 584,873 (95%) 32,858 (53%) 
Others 30,426 (21%) 26,889   (5%) 11,663 (18%) 
Unknown 586 (<1%) 1,431 (<1%) 17,815 (29%) 
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4.2 Medicare Enrollment by Primary Payment Source 
(Refer to Table 4.2) 
 
• The majority of Dual Eligibles and Medicare Only had full 12-month of Part A coverage in 
CY 2005; more than 80% of them had full 12-month of Part B coverage. 
• About one-third of Dual Eligibles were originally eligible for Medicare because of disability; 
in contrast, the majority (91%) of Medicare Only members was originally eligible for 
Medicare because of old age. 
 
Table 4.2 Medicare Enrollment by Primary Payment Source, CY 2005 
CY 2005 
(N=751,572) 
Dual Eligibles 
(N=138,379) 
Medicare Only 
(N=613,193) 
Medicare Enrollment, N (%)  
Part A 12 months 120,241 (87%) 558,126 (91%) 
Part B 12 months 119,840 (87%) 494,322 (81%) 
Not a member in HMO
1
 132,916 (96%) 605,255 (99%) 
Original reason for entitlement   
Old age 92,526 (67%) 556,157 (91%) 
Disabled 45,311 (33%) 56,146 (9%) 
End stage renal disease (ESRD) 244 (02%) 522 (<0.1%) 
Both disabled and ESRD 298 (0.2%) 368 (<0.1%) 
Current reason for entitlement   
Old age 112,053 (81%) 585,908 (96%) 
Disabled 25,812 (19%) 26,424 (4%) 
ESRD 308 (0.2%) 663 (0.1%) 
Both disabled and ESRD 206 (0.2%) 198 (<0.1%) 
 
Note: 1. Including Medicare managed care enrollees who spent some portion of time in the 
Medicare fee-for-service sector in CY 2005. 
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4.3 MassHealth Enrollment by Primary Payment Source 
(Refer to Table 4.3) 
 
• 81% of Dual Eligibles enrolled in MassHealth for 12 months in CY 2005; their average 
MassHealth enrollment period was 329 days. Slightly more than two-thirds of MassHealth 
Only members had 12 months of MassHealth enrollment; the average MassHealth enrollment 
period was 307 days. 
• Over one third of Dual Eligibles and almost half of MassHealth Only members became 
eligible because of a disability. 
• Only a small percentage of people in the study population received services from Department 
of Mental Health.  
 
 
Table 4.3 MassHealth Enrollment by Primary Payment Source, CY 2005 
CY 2005 
(N=200,715) 
Dual Eligibles 
(N=138,379) 
MassHealth Only 
(N=62,336) 
MassHealth Enrollment, N (%)  
Full 12-month enrollment 111,803 (81%) 42,184 (68%) 
Average enrollment days 
(s.d.) 
329 (SD=86) 307 (SD=103) 
Third party liability, except 
Medicare 
234 (<1%) 4,145   (5%) 
Disability
1
 53,967 (39%) 30,408 (49%) 
Receiving DMH services 2,237 (2%) 1,803 (3%) 
 
Note: 1. Disability determined by Social Security Administration or Massachusetts Disability 
Evaluation Services.  
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4.4 Twelve-Month Diagnosed Prevalence of Behavioral Health Disorders  
 
4.4a Overall 12-Month Diagnosed Prevalence of Behavioral Health Disorders 
(BHDs) by Primary Payment Source 
(Refer to Figures 4.4a and Appendix B1) 
 
• The 12-month diagnosed prevalence of BHDs was 20.8% (N=168,960) for Massachusetts 
Medicare and MassHealth beneficiaries aged 55 and over during calendar year 2005 
(N=813,098). 
• Dual Eligibles had the highest prevalence of BHDs (41.6%), SMI (17.7%), and OMI (34.7%) 
• Dual Eligibles and MassHealth Only members had similar diagnosed prevalence of SUD 
(4.5%). 
 
Figure 4.4a Diagnosed Prevalence of Behavioral Health Disorders by Primary Payment 
Source, CY 2005 
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4.4b Twelve-Month Diagnosed Prevalence of BHDs by Age Group and 
Primary Payment Source, CY 05 
(Refer to Figures 4.4b to 4.4e and Appendix B2 to B5) 
 
Ages 55 to 64 (N=134,726, representing 25% of the Massachusetts population in this age range) 
• Twelve-month diagnosed prevalence of BHDs: 
- For Dual Eligibles (N=30,677): 
 Any BHD (51.7%), SMI (28.8%), OMI (38.9%), and SUD (9.3%) 
- For Medicare Only (N=60,967) 
 Any BHD (12.9%), SMI   (5.3%), OMI (9.9%), and SUD (1.7%) 
- For MassHealth Only (N=43,082): 
 Any BHD (31.2%), SMI (15.9%), OMI (20.6%), and SUD (6.5%) 
• The diagnosed prevalence of BHDs among Dual Eligibles was 4 to 6 times higher than 
the Medicare Only group; almost 2 times higher than the MassHealth Only group for all 
BHD groups, except for SUD. 
 
Ages 65 and over (N=679,182, representing 80% of the Massachusetts population aged 65 and 
over.) 
• Twelve-month diagnosed prevalence of BHDs: 
- For Dual Eligibles (N=107,702): 
 Any BHD (38.8%), SMI (14.5%), OMI (33.5%), and SUD (3.2%) 
- For Medicare Only (N=552,226): 
 Any BHD (16.1%), SMI (3.7%), OMI (14.2%), and SUD (1.3%) 
• The diagnosed prevalence of BHDs for the Dual Eligibles was 2.5 to 4 times higher than 
Medicare Only group. 
• Within each primary payment source, the diagnosed prevalence of SMI remained similar 
for the three age groups over 65. 
• The diagnosed prevalence of OMI increased as people aged; this was also reflected in the 
diagnosed prevalence of any BHD. 
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Figure 4.4b Diagnosed Prevalence of Any BHD by Age Group and Primary Payment 
Source, CY 05 
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Figure 4.4c Diagnosed Prevalence of Severe Mental Illness by Age Group and Primary 
Payment Source, CY 05 
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Figure 4.4d Diagnosed Prevalence of Other Mental Illness by Age Group and Primary 
Payment Source, CY 05 
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Figure 4.4e Diagnosed Prevalence of Substance Use Disorders by Age Group and Primary 
Payment Source, CY 05 
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4.5 Diagnosed Co-occurring Behavioral Health Disorders by Age Group and 
Primary Payment Source 
(Refer to Figures 4.5a to 4.5c and Appendix B6 to B8) 
 
Co-occurring Other Mental Illness in People with Severe Mental Illness 
 
Ages 55 to 64 (N=18,878 with SMI) 
• A large proportion of people with SMI had co-occurring OMI: 64.0% among Dual 
Eligibles, 58.4% in Medicare Only groups, and slightly over 50% in MassHealth Only 
group. 
 
Ages 65 and over (N=36,686 with SMI) 
• The proportion of people with SMI having co-occurring OMI was close to 70% in Dual 
Eligibles and the Medicare Only group.  
 
Figure 4.5a Proportion of People with Severe Mental Illness Having Co-occurring Other 
Mental Illness by Age Group and Primary Payment Source, CY 05 
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4.5 Diagnosed Co-occurring Behavioral Health Disorders by Age Group and 
Primary Payment Source, contd. 
 
Co-occurring Substance Use Disorders in People with Severe Mental Illness 
 
Ages 55 to 64 (N=18,878 with SMI) 
• The proportion of people with SMI having co-occurring SUD was 16.3% in Dual 
Eligibles, followed by 13.5% in the MassHealth Only group and 10.2% in the Medicare 
Only group. 
 
Ages 65 and over (N=36,686 with SMI) 
• The proportion of people with SMI having co-occurring SUD was similar in the Dual 
Eligibles and the Medicare Only group (7.7% and 6.8%, respectively). 
• For Dual Eligibles with SMI, the proportion of people having co-occurring SUD 
decreased as people aged (changed from 10.7% in ages 65 to 74 to 3.5% in ages 85 and 
over). 
 
Figure 4.5b Proportion of People with Severe Mental Illness Having Co-occurring 
Substance Use Disorders by Age Group and Primary Payment Source, CY 05 
Proportion of People with SMI
Having Co-occurring SUD, CY05
0%
10%
20%
30%
40%
50%
60%
70%
80%
55-64* 65-74** 75-84** >=85**
Age Groups
P
ro
p
o
rt
io
n
Dual eligible
Medicare only
MassHealth only
 
 
 
 
 
 Twelve-Month Diagnosed Prevalence of Behavioral Health Disorders 
January 2009│Final Version 
22
4.5 Diagnosed Co-occurring Behavioral health Disorders by Age Group and 
Primary Payment Source, contd. 
 
Co-occurring Severe Mental Illness in People with a Substance Use Disorder 
 
Ages 55 to 64 (N=6,710 with SUD) 
• For people with SUD, half of Dual Eligibles and almost one third of the Medicare Only 
group and MassHealth Only group had co-occurring SMI. 
 
Ages 65 and over (N=10,857 with SUD) 
• More than 30% of Dual Eligibles and close to 20% of Medicare Only members with SUD 
had co-occurring SMI. 
 
 
Figure 4.5c Proportion of People with Substance Use Disorders Having Co-occurring 
Severe Mental Illness by Age Group and Primary Payment Source, CY 05 
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4.6 Medical Comorbidity by Age Group and Primary Payment Source 
(Refer to Figures 4.6a to 4.6c and Appendix B9 to B14) 
 
Ages 55 to 64 
• A much higher proportion of people with BHDs had 5 or more selected medical 
conditions than those who had no BHD. 
- Dual Eligibles: 20.8% vs. 13.0% 
- Medicare Only: 14.8% vs. 2.9% 
- MassHealth Only: 8.5% vs. 3.3% 
• Compared to others, Dual Eligibles had a higher proportion of people with 5 or more 
selected medical conditions. 
• Among Dual Eligibles with BHDs, the most prevalent of the selected medical conditions 
studied were hypertension (61.9%), diabetes (36.0%), asthma/chronic obstructive 
pulmonary disease (34.2%), eye diseases (29.4%), and rheumatoid arthritis/osteoarthritis 
(24.5%); percentages in those who had no BHD were 58.1%, 35.7%, 23.4%, 25.1%, and 
18.7%. 
 
Ages 65 and over 
• A much higher proportion of people with BHDs had 5 or more selected medical 
conditions than those who had no BHD. 
- Dual Eligibles: 49.2% vs. 23.3% 
- Medicare Only: 39.1% vs. 15.0% 
• Dual Eligibles had a higher proportion of people with 5 or more selected medical 
conditions than the Medicare Only group. 
• Among Dual Eligibles with BHDs, the most prevalent of the selected medical conditions 
studied were hypertension (76.3%), dementia/Alzheimer’s disease (51.7%), eye diseases 
(44.2%), ischemic heart disease (40.1%), and diabetes (39.1%); percentages in those who 
had no BHD were 68.3%, 16.4%, 38.6%, 26.7%, and 34.1%. 
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Figure 4.6a Proportion of Dual Eligibles with 5 or More Selected Chronic Conditions by 
Age Group and Primary Payment Source, CY 05 
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Figure 4.6b Proportion of Medicare Only with 5 or More Selected Chronic Conditions by 
Age Group and Primary Payment Source, CY 05 
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Figure 4.6c Proportion of MassHealth Only with 5 or More Selected Chronic Conditions by 
Age Group and Primary Payment Source, CY 05 
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4.7 Geographic Variation in Diagnosed Prevalence of BHDs 
(Refer to Figures 4.7 and Appendix B15 and B16; Nantucket County was excluded because 
of a small sample size) 
 
• The diagnosed prevalence of BHDs in all Medicare and MassHealth members aged 65 
and over was similar among counties, for example, prevalence for Any BHDs ranged 
from 18% to 21%. 
• The diagnosed prevalence of Any BHDs in Dual Eligibles aged 65 and over varied 
among counties and ranged from 34% (Suffolk County) to 47% (Barnstable County); the  
prevalence of OMI shows similar variation while it was similar for SMI and SUD. 
 
Figure 4.7 Diagnosed Prevalence of Any Behavioral Health Disorders by County, Dual 
Eligibles, Ages 65 and Over 
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5. SUMMARY AND DISCUSSION 
 
Almost 170,000 Massachusetts Medicare and Medicaid members aged 55 and over had BHD 
diagnoses recorded on their health insurance claims.  Our findings indicate that BHD is a major 
contributor to the overall illness burden of the older population.  In addition to mental health 
needs, people with BHDs had higher medical comorbidity than those without a BHD, as 
measured by the proportion of people with 5 or more selected chronic medical conditions.  This 
is consistent across age groups and primary payment sources.  The level of complexity in 
treatment and care coordination needed is expected to be higher among elderly people with 
BHDs due to the increased overall illness burden than those who without a BHD. 
 
Individuals with dual Medicare and MassHealth enrollment had the highest proportion of BHDs.  
In the 55 to 64 age group, the diagnosed prevalence of BHDs among Dual Eligibles (51.7%) was 
4 times higher than the Medicare Only group (12.9%) and more than 1.5 times higher than the 
MassHealth Only group (31.2%).  In age groups over 65, the diagnosed prevalence among Dual 
Eligibles (38.8%) was almost 2.5 times higher than the Medicare Only group (16.1%).  Dual 
Eligibles also had a higher proportion of people with multiple BHDs and with 5 or more selected 
chronic medical conditions than did the Medicare Only and MassHealth Only groups.  Dual 
Eligibles tended to have lower income, to be older, and to have more disabilities than those in the 
Medicare Only and MassHealth Only groups.  These differences contribute to the higher disease 
burden in the Dual Eligibles. 
 
According to existing studies, the prevalence of substance use disorders in the elderly population 
is low.  For example, the ECA estimated this prevalence to be 2.8% for people aged 55 and over. 
Our findings show higher rates, with 7% of Dual Eligibles and 9% of MassHealth Only members 
aged 55 to 64 having BHDs. For people aged 65 and over, 3% of Dual Eligibles, but less than 
2% of Medicare Only members, have BHDs.  
 
However, as the baby boom generation ages, the prevalence of substance use disorders is 
expected to increase. Patterson and colleagues (1999) estimated that 1.1 million more individuals 
in the baby boom generation were using drugs than in the older non-baby-boom generation 
(Patterson & Jeste, 1999).  The 2007 National Survey on Drug Use and Health (NSDUH) shows 
an increase in drug use among people aged 55 to 59, the oldest cohort of the baby boom 
generation in this survey.  So, despite the low rates of diagnosed substance use disorders 
observed in our analysis, other evidence suggests there may be a need for additional resources in 
this area.  Drug and alcohol misuse increases Medicaid and Medicare expenditures for medical 
as well as behavioral healthcare.  A recent study of six state Medicaid programs showed a 
particularly large impact of substance use disorders on medical treatment for members over age 
50 (Clark, Samnaliev, & McGovern, in press). 
 
While the use of merged Medicare and MassHealth claims data provides a population-based 
perspective on the diagnosed prevalence of BHDs, our findings may still underestimate the true 
prevalence of BHDs.  This is mainly due to the under-reporting of BHDs by providers and 
treatment seeking behavior of people with BHDs.  To minimize the underestimation from under-
reporting, our disease identification included all diagnosis fields (primary and others) and used 
one claim in an inpatient or ambulatory setting, as the minimum requirement for inclusion.  Our 
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findings on the overall prevalence of BHDs and the prevalence of SMI are similar to national 
estimates reported in the ECA study.  
 
The increasing number of elderly people with BHDs, along with their high disease burden, poses 
serious challenges to the current mental health care delivery system for treating the elderly 
population in Massachusetts.  Innovative programs for mental health services delivery and better 
coordination with other medical care need to be developed to address these challenges.  The 
diagnosed prevalence of BHDs reported in this report is the first part of a larger Medicare and 
Medicaid claims data analysis.  Further analyses will focus on mental health treatment received 
among people with BHDs to examine where mental health services are delivered and what 
proportion are provided by mental health specialists.  We will also analyze health care 
expenditures.  Results will provide a more comprehensive picture of how mental health services 
are delivered, who provides treatment, what types of treatment are provided, variation in 
treatment across geographic locations, and associated expenditures by primary payment sources 
and settings.  The information will allow us to identify opportunities for systematic changes to 
better serve elders with BHDs. 
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Appendix 
 
A1. Behavioral Health Disorders 
 
Group Broad classification Includes: ICD9-CM-Codes 
Severe Mental 
Illness 
Bipolar disorder Bipolar disorder 2960, 2961, 2964-2969 
 Major depression Major depression 2963, 2962 
 Paranoid States Paranoid States 297 
 Schizophrenia Schizophrenia 295 
Other Mental 
Illness 
Other depression Other depression 2980, 3004, 3090, 3091, 311  
 Anxiety Anxiety 3000 
 
Other mental illness 
 2981-2989, 3001-3003, 
3005-3009, 301, 302, 306- 
308,  3092-3099, 312-316 
Substance Use 
Disorders 
Alcohol related  291, 303, 3050, 5353, 
5710-5713 
 Drug-related  292, 304, 3052-3059, 6483 
 
Additional ICD-9-CM surgical codes, CPT codes for identifying substance use disorders 
Diagnosis ICD-9-CM Surgical 
procedure codes 
CPT/HCPCs codes 
Substance 
Use Disorders 
– Alcohol 
Related 
'9446', '9453', '9461', 
'9462','9463', 
'9467','9468','9469' 
'H0005', 'H0006', 'H0007', 'H0008', 
'H0009', 'H0010', 
'H0011','H0012','H0013','H0014','H0
015','H0016','H0017','H0020','H0021'
,'H0021', 'H0022', 'H0023', 'H0030', 
'H0047','H2034','H2035','H2036', , 
'T1006',  'T1007', 'T1008', 'T1009', 
'T1010', 'T1011', 'T1012', 
,'X2216','X2217','X2218','X2219',  
'X2223',  'X2224','X2225', 'X2226', 
'X2227', 'X2228', 'X2229', ,'X5605', 
'X5607','ZZ116', 'ZZ126', 'ZZ136', 
'ZZ146','ZZ156', 'ZZ945' 
Substance 
Use Disorders 
– Drug 
Related 
'9445', '9454', '9464', 
'9465', '9466', '9467', 
'9468', '9469' 
'S9475', 'X2197', 'X2198', 'X2199', 
'X2200', 'X2202', 'X2203', 'X2205', 
'X2214','X2215', 'X2222', 'X5604', 
'X5606','ZZ116', 'ZZ126', 'ZZ944',   
Note: Drug and alcohol related disorder share some HCPCS codes. 
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A2. Selected Chronic Conditions (arranged by major diagnostic classifications) 
 
Diagnosis ICD9-Diagnosis 
Codes begin with: 
ICD9-Surgical 
procedure codes 
begin with: 
DRG codes CPT/HCPCs 
codes begin with: 
Diabetes 
Mellitus 
 
250, 3572 ,3620, 
36201, 36202, 36641, 
6480 
 ‘294’, ‘205’  
Chronic 
Kidney 
Disease 
0160, 0954, 1890, 
1899, 2230, 23691, 
25040, 25041, 25042, 
25043, 2714, 27141, 
28311, 40301, 40311, 
40391, 40402, 40403, 
40412, 40413, 40492, 
40493, 4401, 4421, 
5724, 58,  591, 7531, 
7532 , 7944 
   
Atrial 
Fibrillation 
42731    
Ischemic 
Heart Disease  
410-414 360, 361, 362, 
3631, 3632 
‘121’, 
‘122’, 
‘156’, ‘526’ 
 
3351, 33521-
33523, 33533-
33536, 33542, 
33545, 92975, 
92977, 92980, 
92982, 92995, 
33140, 33141 
Congestive 
Heart Failure 
428, 40211, 40291, 
39891, 40201, 40401, 
40411, 40491, 40403 
40413, 40493 
   
Hypertension 401-405    
Stroke 430, 431, 434.00, 
434.01, 434.10, 
434.11, 434.90, 
434.91, 435.0, 435.1, 
435.3, 435.8, 435.9, 
436, 997.02 
   
Chronic 
Obstructive 
Pulmonary 
Disease 
(COPD)
 1
 
491-492,494, 496,  
2932, 5064, 5181, 
5182, 4932, 493 
   
Osteoarthritis 715    
Osteoporosis 733    
Hip/Pelvic 808, 820.    
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Fracture 
Parkinsonism  332    
Alzheimer 
and Other 
Dementia 
331, 293, 294, 310, 
290 
   
Eye disease
2
 36455, 36510, 36511, 
36512, 36515, 36589, 
3659, 36285, 36500- 
36504, 37714, 36520-
36524, 36541, 36561, 
36631, v801, 366, 
37926, 37931, 37939, 
74331, 74332, 74333, 
99653, v431, v802, 
3625 
   
Cancer
3
 185, 2334 
162, 2312 
174,  2330 
182, 2332 
154.0, 154.1, 153.0, 
153.1-153.9, 230.3, 
230.4 
   
Notes: 1. COPD includes chronic bronchitis, emphysema, asthma and other chronic respiratory disease. 
            2. Eye disease includes glaucoma, cataract and macular degeneration. 
            3. Cancer includes prostate cancer, lung cancer, breast cancer, endometrial cancer, and colorectal cancer. 
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B1. Diagnosed Prevalence of Behavioral Health Disorders by Primary Payment Source, CY 
2005 
 
CY 2005 
(Total N=813,098) 
Dual Eligibles 
(N=138,379) 
Medicare Only 
(N=613,193) 
MassHealth Only 
(N=62,336) 
Diagnosed Prevalence, N (%)   
Any BHD
1
 57,611 (41.6) 96,624 (15.8) 14,725 (23.6) 
Severe 
mental 
illness 
 
Schizophrenia/ 
paranoid 
24,468 
(17.7) 
7,593 
(5.5) 
23,743 
(3.9) 
2,756 
(0.5) 
7,353 
(11.8) 
1,750 
(2.8) 
Bipolar 7,144 
(5.2) 
6,120 
(1.0) 
1,633 
(2.6) 
Major 
depression 
15,057 
(10.9) 
17,915 
(2.9) 
5,039 
(8.1) 
Other 
mental 
illness 
Other 
depression 
47,989 
(34.7) 
29,398 
(21.2) 
84,385 
(13.8) 
44,403 
(7.2) 
9,789 
(15.7) 
5,373 
(8.6) 
Anxiety 16,713 
(12.1) 
32,490 
(5.3) 
3,160 
(5.1) 
Others
2
 25,695 
(18.6) 
38,796 
(6.3) 
5,290 
(8.5) 
Substance 
use 
disorders 
Alcohol abuse 
or dependence 
6,276 
(4.5) 
4,720 
(3.4) 
8,422 
(1.4) 
6,353 
(1.0) 
2,869 
(4.6) 
2,013 
(3.2) 
Drug abuse or 
dependence 
2,204 
(1.6) 
2,444 
(0.4) 
1,226 
(2.0) 
Note: 1. Including severe mental illness, other mental illness, and substance use disorders. 
 2. For example, unspecified psychosis, adjustment reaction with mixed emotional 
features, and prolonged posttraumatic stress disorder 
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B2. Diagnosed Prevalence of Any Behavioral Health Disorder by Age Group and Primary 
Payment Source, CY 05 
 
BHD 
Dual 
Eligibles 
Medicare 
Only 
MassHealth 
Only 
55-64 51.7% 12.9% 31.2% 
65-74 34.4% 12.8% 7.6% 
75-84 38.5% 17.9% 5.9% 
>=85 47.0% 22.7% 5.1% 
All ages 41.6% 15.8% 23.6% 
55-64 51.7% 12.9% 31.2% 
>=65 38.8% 16.1% 6.7% 
    
 
Number of people w/ any BHD 
Numerator 
Dual 
Eligibles 
Medicare 
Only 
MassHealth 
Only 
55-64 15853 7840 13432 
65-74 15326 34078 817 
75-84 14539 37152 335 
>=85 11893 17554 141 
All ages 57611 96624 14725 
55-64 15853 7840 13432 
>=65 41758 88784 1293 
    
 
Number of people in the study population 
Denominator 
Dual 
Eligibles 
Medicare 
Only 
MassHealth 
Only 
55-64 30677 60967 43082 
65-74 44602 267251 10795 
75-84 37791 207670 5689 
>=85 25309 77305 2770 
All ages 138379 613193 62336 
55-64 30677 60967 43082 
>=65 107702 552226 19254 
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B3. Diagnosed Prevalence of Severe Mental Illness by Age Group and Primary Payment 
Source, CY 05 
 
SMI 
Dual 
Eligibles 
Medicare 
Only 
MassHealth 
Only 
55-64 28.8% 5.3% 15.9% 
65-74 14.7% 3.1% 3.1% 
75-84 14.6% 4.1% 2.2% 
>=85 14.2% 4.9% 1.7% 
All ages 17.7% 3.9% 11.8% 
55-64 28.8% 5.3% 15.9% 
>=65 14.5% 3.7% 2.6% 
    
 
Number of people w/ SMI   
Numerator 
Dual 
Eligibles 
Medicare 
Only 
MassHealth 
Only 
55-64 8822 3211 6845 
65-74 6546 8279 336 
75-84 5499 8502 125 
>=85 3601 3751 47 
All ages 24468 23743 7353 
55-64 8822 3211 6845 
>=65 15646 20532 508 
    
 
Number of people in the study population 
Denominator 
Dual 
Eligibles 
Medicare 
Only 
MassHealth 
Only 
55-64 30677 60967 43082 
65-74 44602 267251 10795 
75-84 37791 207670 5689 
>=85 25309 77305 2770 
All ages 138379 613193 62336 
55-64 30677 60967 43082 
>=65 107702 552226 19254 
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B4. Diagnosed Prevalence of Other Mental Illness by Age Group and Primary Payment 
Source, CY 05 
 
OMI 
Dual 
Eligibles 
Medicare 
Only 
MassHealth 
Only 
55-64 38.9% 9.9% 20.6% 
65-74 27.9% 10.8% 5.4% 
75-84 33.7% 16.0% 4.1% 
>=85 42.9% 21.0% 3.7% 
All ages 34.7% 13.8% 15.7% 
55-64 38.9% 9.9% 20.6% 
>=65 33.5% 14.2% 4.8% 
    
 
Number of people w/ OMI   
Numerator 
Dual 
Eligibles 
Medicare 
Only 
MassHealth 
Only 
55-64 11944 6039 8873 
65-74 12449 28972 581 
75-84 12747 33137 233 
>=85 10849 16237 102 
All ages 47989 84385 9789 
55-64 11944 6039 8873 
>=65 36045 78346 916 
    
 
Number of people in the study population 
Denominator 
Dual 
Eligibles 
Medicare 
Only 
MassHealth 
Only 
55-64 30677 60967 43082 
65-74 44602 267251 10795 
75-84 37791 207670 5689 
>=85 25309 77305 2770 
All ages 138379 613193 62336 
55-64 30677 60967 43082 
>=65 107702 552226 19254 
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B5. Diagnosed Prevalence of Substance Use Disorders by Age Group and Primary Payment 
Source, CY 05 
 
SUD 
Dual 
Eligibles 
Medicare 
Only 
MassHealth 
Only 
55-64 9.3% 1.7% 6.5% 
65-74 4.4% 1.3% NA 
75-84 2.8% 1.4% NA 
>=85 1.6% 1.2% NA 
All ages 4.5% 1.4% 4.6% 
55-64 9.3% 1.7% 6.5% 
>=65 3.2% 1.3% 0.4% 
    
 
Number of people w/ SUD   
Numerator 
Dual 
Eligibles 
Medicare 
Only 
MassHealth 
Only 
55-64 2860 1058 2792 
65-74 1952 3518 NA 
75-84 1056 2920 NA 
>=85 408 926 NA 
All ages 6276 8422 2869 
55-64 2860 1058 2792 
>=65 3416 7364 77 
    
 
Number of people in the study population 
Denominator 
Dual 
Eligibles 
Medicare 
Only 
MassHealth 
Only 
55-64 30677 60967 43082 
65-74 44602 267251 10795 
75-84 37791 207670 5689 
>=85 25309 77305 2770 
All ages 138379 613193 62336 
55-64 30677 60967 43082 
>=65 107702 552226 19254 
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B6. Proportion of People with Severe Mental Illness Having Co-occurring Other Mental 
Illness by Age Group and Primary Payment Source, CY 05 
Co-occurring OMI in people with SMI  
 
Dual 
Eligibles 
Medicare 
Only 
MassHealth 
Only 
55-64 64.0% 58.4% 51.3% 
65-74 66.4% 60.8% 39.9% 
75-84 72.8% 68.8% NA 
>=85 73.6% 74.1% NA 
All ages 68.1% 65.4% 50.2% 
55-64 64.0% 58.4% 51.3% 
>=65 70.3% 66.5% 35.0% 
    
 
Number of SMI people w/ OMI 
Numerator 
Dual 
Eligibles 
Medicare 
Only 
MassHealth 
Only 
55-64 5648 1874 3511 
65-74 4349 5035 134 
75-84 4004 5847 NA 
>=85 2651 2781 NA 
All ages 16652 15537 3689 
55-64 5648 1874 3511 
>=65 11004 13663 178 
    
 
Number of people with SMI 
Denominator 
Dual 
Eligibles 
Medicare 
Only 
MassHealth 
Only 
55-64 8822 3211 6845 
65-74 6546 8279 336 
75-84 5499 8502 125 
>=85 3601 3751 47 
All ages 24468 23743 7353 
55-64 8822 3211 6845 
>=65 15646 20532 508 
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B7. Proportion of People with Severe Mental Illness Having Co-occurring Substance Use 
Disorders by Age Group and Primary Payment Source, CY 05 
Co-occurring SUD in people with SMI  
 
Dual 
Eligibles 
Medicare 
Only 
MassHealth 
Only 
55-64 16.3% 10.2% 13.5% 
65-74 10.7% 7.9% NA 
75-84 7.0% 6.7% NA 
>=85 3.5% 4.5% NA 
All ages 10.8% 7.2% 12.8% 
55-64 16.3% 10.2% 13.5% 
>=65 7.7% 6.8% NA 
    
 
Number of SMI people w/ SUD 
Numerator 
Dual 
Eligibles 
Medicare 
Only 
MassHealth 
Only 
55-64 1442 329 925 
65-74 699 651 NA 
75-84 385 568 NA 
>=85 127 170 NA 
All ages 2653 1718 941 
55-64 1442 329 925 
>=65 1211 1389 NA 
    
 
Number of people with SMI 
Denominator 
Dual 
Eligibles 
Medicare 
Only 
MassHealth 
Only 
55-64 8822 3211 6845 
65-74 6546 8279 336 
75-84 5499 8502 125 
>=85 3601 3751 47 
All ages 24468 23743 7353 
55-64 8822 3211 6845 
>=65 15646 20532 508 
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B8. Proportion of People with Substance Use Disorders Having Co-occurring Severe 
Mental Illness by Age Group and Primary Payment Source, CY 05 
Co-occurring SMI in people with SUD  
 
Dual 
Eligibles 
Medicare 
Only 
MassHealth 
Only 
55-64 50.4% 31.1% 33.1% 
65-74 35.8% 18.5% NA 
75-84 36.5% 19.5% NA 
>=85 31.1% 18.4% NA 
All ages 42.3% 20.4% 32.8% 
55-64 50.4% 31.1% 33.1% 
>=65 35.5% 18.9% NA 
    
 
Number of SUD people w/ SMI 
Numerator 
Dual 
Eligibles 
Medicare 
Only 
MassHealth 
Only 
55-64 1442 329 925 
65-74 699 651 NA 
75-84 385 568 NA 
>=85 127 170 NA 
All ages 2653 1718 941 
55-64 1442 329 925 
>=65 1211 1389 NA 
    
 
Number of people with SUD 
Denominator 
Dual 
Eligibles 
Medicare 
Only 
MassHealth 
Only 
55-64 2860 1058 2792 
65-74 1952 3518 NA 
75-84 1056 2920 NA 
>=85 408 926 NA 
All ages 6276 8422 2869 
55-64 2860 1058 2792 
>=65 3416 7364 77 
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B9. Proportion of Dual Eligibles with 5 or More Selected Chronic Conditions by Age 
Group, CY 05 
Dual Eligibles   
 
Any BHD (SMI, 
OMI, or SUD) No BHD 
55-64 20.8% 13.0% 
65-74 36.8% 16.2% 
75-84 54.4% 26.2% 
>=85 58.8% 33.9% 
All ages 41.4% 21.4% 
55-64 20.8% 13.0% 
>=65 49.2% 23.3% 
   
 
Number of Dual Eligibles w/ >=5 chronic conditions 
 
Numerator Any BHD No BHD 
55-64 3290 1932 
65-74 5644 4749 
75-84 7911 6086 
>=85 6994 4549 
All ages 23839 17316 
55-64 3290 1932 
>=65 20549 15384 
   
 
Number of Dual Eligibles  
Denominator Any BHD No BHD 
55-64 15853 14824 
65-74 15326 29276 
75-84 14539 23252 
>=85 11893 13416 
All ages 57611 80768 
55-64 15853 14824 
>=65 41758 65944 
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B10. Proportion of Medicare Only with 5 or More Selected Chronic Conditions by Age 
Group, CY 05 
Medicare Only  
 
Any BHD (SMI, 
OMI, or SUD) No BHD 
55-64 14.8% 2.9% 
65-74 24.6% 8.3% 
75-84 44.1% 20.4% 
>=85 56.6% 26.1% 
All ages 37.1% 13.8% 
55-64 14.8% 2.9% 
>=65 39.1% 15.0% 
   
 
Number of Medicare Only members w/ >=5 chronic 
conditions 
Numerator Any BHD No BHD 
55-64 1157 1548 
65-74 8371 19241 
75-84 16400 34732 
>=85 9934 15595 
All ages 35862 71116 
55-64 1157 1548 
>=65 34705 69568 
   
 
Number of Medicare Only 
members  
Denominator Any BHD No BHD 
55-64 7840 53127 
65-74 34078 233173 
75-84 37152 170518 
>=85 17554 59751 
All ages 96624 516569 
55-64 7840 53127 
>=65 88784 463442 
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B11. Proportion of MassHealth Only with 5 or More Selected Chronic Conditions by Age 
Group, CY 05 
MassHealth Only  
 
Any BHD (SMI, 
OMI, or SUD) No BHD 
55-64 8.5% 3.3% 
65-74 10.5% 1.7% 
75-84 16.1% 2.7% 
>=85 NA NA 
All ages 8.8% 2.8% 
55-64 8.5% 3.3% 
>=65 11.8% 2.0% 
   
 
Number of MassHealth Only members w/ >=5 
chronic conditions 
Numerator Any BHD No BHD 
55-64 1140 972 
65-74 86 174 
75-84 54 145 
>=85 NA NA 
All ages 1293 1325 
55-64 1140 972 
>=65 153 353 
   
 
Number of MassHealth Only members 
Denominator Any BHD No BHD 
55-64 13432 29650 
65-74 817 9978 
75-84 335 5354 
>=85 141 2629 
All ages 14725 47611 
55-64 13432 29650 
>=65 1293 17961 
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B15. Twelve-Month Diagnosed Prevalence of Behavioral Health Disorders by County, All 
Payment Sources, Age 65 and Over, CY 05 
  12-month Diagnosed Prevalence 
County N (total) Any BHD SMI OMI SUD 
BARNSTABLE 48436 19% 5% 17% 2% 
BERKSHIRE 22686 19% 5% 17% 1% 
BRISTOL 65381 20% 5% 18% 1% 
DUKES 2300 19% 7% 16% NA 
ESSEX 83508 20% 5% 17% 2% 
FRANKLIN 7442 18% 5% 16% 2% 
HAMPDEN 49855 18% 5% 16% 2% 
HAMPSHIRE 16144 19% 5% 16% 2% 
MIDDLESEX 140996 19% 6% 16% 1% 
NANTUCKET 1083 14% NA 13% NA 
NORFOLK 70624 19% 5% 17% 1% 
PLYMOUTH 51359 19% 5% 17% 2% 
SUFFOLK 63479 21% 6% 18% 2% 
WORCESTER 55222 20% 5% 18% 2% 
OVERALL 678515 19% 5% 17% 2% 
Note: “NA” – Not reported due to the small number of individuals in the cell. 
 
B16. Twelve-Month Diagnosed Prevalence of Behavioral Health Disorders by County, Dual 
Eligibles, Age 65 and Over, CY 05 
  12-month Diagnosed Prevalence 
County N (total) Any BHD SMI OMI SUD 
BARNSTABLE 3202 47% 16% 40% 4% 
BERKSHIRE 2768 42% 15% 37% 3% 
BRISTOL 14170 39% 13% 35% 2% 
DUKES 172 45% NA 43% NA 
ESSEX 12727 39% 15% 34% 3% 
FRANKLIN 1056 45% 17% 39% NA 
HAMPDEN 9705 37% 14% 31% 3% 
HAMPSHIRE 1845 45% 16% 39% 3% 
MIDDLESEX 17648 38% 15% 32% 3% 
NANTUCKET NA NA NA NA NA 
NORFOLK 8151 40% 16% 35% 3% 
PLYMOUTH 6881 43% 16% 38% 4% 
SUFFOLK 19189 34% 13% 29% 4% 
WORCESTER 10045 42% 16% 36% 3% 
OVERALL 107627 39% 15% 33% 3% 
Note: “NA” – Not reported due to the small number of individuals in the cell. 
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